Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 6, 2021; 9(25): 7498-7503
Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7498
Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7498
Figure 1 Changes in brain metastases after olaparib treatment.
A: The lesion before olaparib treatment; B: At 7 mo after treatment; C: At 13.5 mo after treatment; D: At 13.5 mo after treatment.
- Citation: Zhang L, Wang J, Cui LZ, Wang K, Yuan MM, Chen RR, Zhang LJ. Successful treatment of refractory lung adenocarcinoma harboring a germline BRCA2 mutation with olaparib: A case report. World J Clin Cases 2021; 9(25): 7498-7503
- URL: https://www.wjgnet.com/2307-8960/full/v9/i25/7498.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i25.7498